Chopas James George (CIK 1836430) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (65,955 shares), Sell APLS (6,250 shares), Sell APLS (5,625 shares), Buy APLS (8,394 shares), Sell APLS (8,394 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 65,955 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 6,250 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 5,625 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 8,394 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 8,394 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 16,150 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 16,150 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 5,625 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 8,075 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 2,406 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 4,156 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 9,444 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 16,150 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 8,075 | $0 |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 16,150 | $0 |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 2,064 | $44,933 |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 726 | $14,368 |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 873 | $19,372 |
| 2025-09-17 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 189 | $4,572 |
| 2025-09-03 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 548 | $15,388 |
| 2025-06-20 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 6,250 | $0 |
| 2025-03-18 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 183 | $4,542 |
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 1,096 | $33,351 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Buy | 12,591 | $0 |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | Sell | 715 | $21,421 |
Source: SEC Form 4 filings · as of 2026-05-14